Recombinant multi-species CRIPT protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CRIPT protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a protein that binds to the PDZ3 peptide recognition domain. The encoded protein may modulates protein interactions with the cytoskeleton. A mutation in this gene resulted in short stature with microcephaly and distinctive facies. [provided by RefSeq, Jun 2014]
The Alternative Names of target: 1200020A08Rik,CRIPT,Cript,Cysteine-rich PDZ-binding protein,Cysteine-rich interactor of PDZ three (Cysteine-rich interactor of PDZ3),HSPC139,RTS3,SSMDF

Target products collectionGo to CRIPT products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP13748-Ag-1/ GM-Tg-hg-IP13748-Ag-2 Human CRIPT protein Human
GM-Tg-rg-IP13748-Ag-1/ GM-Tg-rg-IP13748-Ag-2 Rat CRIPT protein Rat
GM-Tg-mg-IP13748-Ag-1/ GM-Tg-mg-IP13748-Ag-2 Mouse CRIPT protein Mouse
GM-Tg-cynog-IP13748-Ag-1/ GM-Tg-cynog-IP13748-Ag-2 Cynomolgus/Rhesus macaque CRIPT protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP13748-Ag-1/ GM-Tg-felg-IP13748-Ag-2 Feline CRIPT protein Feline
GM-Tg-cang-IP13748-Ag-1/ GM-Tg-cang-IP13748-Ag-2 Canine CRIPT protein Canine
GM-Tg-bovg-IP13748-Ag-1/ GM-Tg-bovg-IP13748-Ag-2 Bovine CRIPT protein Bovine
GM-Tg-equg-IP13748-Ag-1/ GM-Tg-equg-IP13748-Ag-2 Equine CRIPT protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP13748-Ag-1/ GM-Tg-hg-IP13748-Ag-2; GM-Tg-rg-IP13748-Ag-1/ GM-Tg-rg-IP13748-Ag-2;
GM-Tg-mg-IP13748-Ag-1/ GM-Tg-mg-IP13748-Ag-2; GM-Tg-cynog-IP13748-Ag-1/ GM-Tg-cynog-IP13748-Ag-2;
GM-Tg-felg-IP13748-Ag-1/ GM-Tg-felg-IP13748-Ag-2; GM-Tg-cang-IP13748-Ag-1/ GM-Tg-cang-IP13748-Ag-2;
GM-Tg-bovg-IP13748-Ag-1/ GM-Tg-bovg-IP13748-Ag-2; GM-Tg-equg-IP13748-Ag-1/ GM-Tg-equg-IP13748-Ag-2
Products Name CRIPT protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CRIPT
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CRIPT protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.